Previous Nav
Net Change on 20-05-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Divi's Laboratories Ltd.
Max Healthcare Institute Ltd.
Dr. Reddy's Laboratories Ltd.
Mankind Pharma Ltd.
Aster DM Healthcare Ltd.
Clearing Corporation of India Ltd.
Torrent Pharmaceuticals Ltd.
Krishna Inst of Medical Sciences Ltd.
Ajanta Pharma Ltd.
Abbott India Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Global Health Ltd.
ICICI Lombard General Insurance Co. Ltd.
Cipla Ltd.
PB Fintech Ltd.
Dr. Lal Path Labs Ltd.
Jupiter Life Line Hospitals Ltd.
Navin Fluorine International Ltd.
IPCA Laboratories Ltd.
Syngene International Ltd.
Rainbow Children's Medicare Ltd.
Sagility India Ltd.
Neuland Laboratories Ltd.
Sanofi Consumer Healthcare India Ltd.
Sanofi India Ltd.
Zydus Lifesciences Ltd.
Sai Life Sciences Ltd
Orchid Pharma Ltd.
Net Receivables / (Payables)
Akums Drugs And Pharmaceuticals Ltd.
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Business Support
Insurance
Fintech
Chemicals
Cash
Equity
PGIM India Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to PGIM India Mutual Fund. It was launched on 06-Dec-2024 and currently has an AUM of ₹107.51 crore. PGIM India Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index.
The NAV of PGIM India Healthcare Fund ended down ₹-0.08(-0.83%)yesterday to ₹9.61.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The PGIM India Healthcare Fund is managed by Puneet Pal and Anandha Padmanabhan Anjeneyan.
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051